tiprankstipranks
Ideaya Biosciences appoints Stu Dorman as chief commercial officer
PremiumThe FlyIdeaya Biosciences appoints Stu Dorman as chief commercial officer
5d ago
Gilead announces data from interim analysis of Phase 3 ASSURE study
Premium
The Fly
Gilead announces data from interim analysis of Phase 3 ASSURE study
7d ago
Wolfe Research starts Gilead at Outperform on ‘multiple shots on goal’
Premium
The Fly
Wolfe Research starts Gilead at Outperform on ‘multiple shots on goal’
8d ago
Gilead price target raised to $95 from $85 at TD Cowen
PremiumThe FlyGilead price target raised to $95 from $85 at TD Cowen
14d ago
Gilead price target raised to $97 from $83 at Truist
Premium
The Fly
Gilead price target raised to $97 from $83 at Truist
14d ago
Gilead price target raised to $103 from $95 at Raymond James
Premium
The Fly
Gilead price target raised to $103 from $95 at Raymond James
14d ago
Gilead price target raised to $80 from $70 at Cantor Fitzgerald
PremiumThe FlyGilead price target raised to $80 from $70 at Cantor Fitzgerald
15d ago
Gilead price target raised to $105 from $95 at Oppenheimer
Premium
The Fly
Gilead price target raised to $105 from $95 at Oppenheimer
15d ago
Gilead price target raised to $105 from $95 at Piper Sandler
Premium
The Fly
Gilead price target raised to $105 from $95 at Piper Sandler
15d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100